Lenzing (LNZ) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
16 Jan, 2026Executive summary
Revenue grew 5% year-over-year to nearly €2 billion for the first nine months of 2024, with Q3 revenue at €647 million, driven by higher fiber sales and improved volumes despite weak market recovery.
EBITDA rose 20% year-over-year to €264 million in Q1–Q3 2024, with Q3 EBITDA at €99 million and margin up to 15%, supported by cost excellence and performance program benefits.
Free cash flow was positive for the fifth consecutive quarter, reaching €192 million for the nine months, and net financial debt decreased by €217 million to €1.36 billion.
Net loss after tax was €111.1 million, impacted by a €77.7 million tax expense, including a €25.8 million tax transfer due to group structure changes.
The performance program, launched in Q3 2023, is ahead of schedule, targeting over €100 million in annualized cost savings for 2025.
Financial highlights
Q3 2024 revenue was €647 million (+5% YoY); Q1–Q3 2024 revenue reached €1,958 million (+5% YoY).
Q3 2024 EBITDA was €99 million (+20% YoY, 15% margin); Q1–Q3 2024 EBITDA was €264 million (+20% YoY, 13% margin).
EBIT for Q1–Q3 2024 turned positive at €38 million, up from a loss in the prior year; net loss narrowed to €111.1 million.
Free cash flow for Q1–Q3 2024 was €192 million, up from negative €138 million in the prior year.
Net financial debt at the end of Q3 2024 was €1,357 million, down from €1,574 million a year earlier.
Outlook and guidance
Guidance for 2024 financial year confirmed: EBITDA expected to be higher than previous year, with ongoing margin improvements and cost excellence.
Market visibility remains low due to global economic and geopolitical uncertainties.
Stable demand in bulk and continued demand growth for sustainable specialty fibers in textiles, hygiene, and medical sectors expected.
Energy and raw material costs are anticipated to remain elevated.
Performance program is ahead of schedule and expected to further improve earnings in coming quarters.
Latest events from Lenzing
- Adjusted EBITDA rose 7.6% to EUR 426 million despite a 2.3% revenue decline.LNZ
Q4 202519 Mar 2026 - EBITDA and free cash flow rose, specialty fibers and cost savings drove growth amid market headwinds.LNZ
Q2 20242 Feb 2026 - EBITDA up 30%, specialty fiber share at 93%, and further gains expected in 2025.LNZ
Q4 202425 Dec 2025 - EBITDA more than doubled and free cash flow turned positive despite trade and cost pressures.LNZ
Q1 202524 Nov 2025 - EBITDA rose over 63% as revenue, profit, and liquidity improved despite tariff uncertainty.LNZ
Q2 202523 Nov 2025 - EBITDA and revenue rose, but Q3 earnings fell on restructuring; liquidity and outlook improved.LNZ
Q3 202513 Nov 2025 - Premiumization, cost savings, and innovation support strong EBITDA growth to 2027.LNZ
Investor Update30 Sep 2025